Srikanta Dash
Overview
Explore the profile of Srikanta Dash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
5595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chandra P, Kundu A, Hazari S, Chandra S, Bao L, Ooms T, et al.
Mol Ther
. 2024 Dec;
33(1):422.
PMID: 39675355
No abstract available.
2.
Chandra P, Hazari S, Poat B, Gunduz F, Prabhu R, Liu G, et al.
Virol J
. 2024 Nov;
21(1):274.
PMID: 39487495
No abstract available.
3.
Jena L, Behera S, Dash S, Sethy P
Contemp Oncol (Pozn)
. 2024 May;
28(1):37-44.
PMID: 38800533
Introduction: This study introduces a novel methodology for classifying human papillomavirus (HPV) using colposcopy images, focusing on its potential in diagnosing cervical cancer, the second most prevalent malignancy among women...
4.
Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, et al.
J Hepatocell Carcinoma
. 2024 May;
11:839-855.
PMID: 38741679
Introduction: Sorafenib, an FDA-approved drug for advanced hepatocellular carcinoma (HCC) treatment, encounters resistance in many patients. Deciphering the mechanisms underlying sorafenib resistance is crucial for devising alternative strategies to overcome...
5.
Koksal A, Ekmen N, Aydin Y, Nunez K, Sandow T, Delk M, et al.
J Hepatocell Carcinoma
. 2023 Nov;
10:1935-1954.
PMID: 37936599
Introduction: Extracellular vesicles could serve as a non-invasive biomarker for early cancer detection. However, limited methods to quantitate cancer-derived vesicles in the native state remain a significant barrier to clinical...
6.
Lin D, Chen Y, Koksal A, Dash S, Aydin Y
Cell Commun Signal
. 2023 May;
21(1):102.
PMID: 37158967
Background: Chronic hepatitis C virus (HCV) infection causes hepatocellular carcinoma (HCC). The HCC risk, while decreased compared with active HCV infection, persists in HCV-cured patients by direct-acting antiviral agents (DAA)....
7.
Dash S, Sethy P, Behera S
Cancer Inform
. 2023 Apr;
22:11769351231161477.
PMID: 37008072
The second most frequent malignancy in women worldwide is cervical cancer. In the transformation(transitional) zone, which is a region of the cervix, columnar cells are continuously converting into squamous cells....
8.
Koksal A, Thevenot P, Aydin Y, Nunez K, Sandow T, Widmer K, et al.
J Hepatocell Carcinoma
. 2022 Sep;
9:959-972.
PMID: 36105695
Background And Aim: HCC development in liver cirrhosis is associated with impaired autophagy leading to increased production of extracellular vesicles (EVs) including exosomes and microvesicles. The goal of the study...
9.
Aydin Y, Koksal A, Thevenot P, Chava S, Heidari Z, Lin D, et al.
J Hepatocell Carcinoma
. 2021 Dec;
8:1579-1596.
PMID: 34917553
Background And Aims: Hepatocellular carcinoma (HCC) developing in the context of preexisting cirrhosis is characterized by impaired autophagy that results in increased exosome release. This study was conducted to determine...
10.
Aydin Y, Chedid M, Chava S, Danielle Williams D, Liu S, Hagedorn C, et al.
Sci Rep
. 2021 Sep;
11(1):17779.
PMID: 34471176
No abstract available.